1. Home
  2. Companies
  3. SymBiosis
SY

SymBiosis

About

We invest in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials.

We are curious, rigorous, collaborative, and passionate about our work; we are also long-term investors in our team.

Similar companies

PL

Pivotal Life Sciences

Our deep resources and industry knowledge make us the ideal partner to scientists and entrepreneurs worldwide. Pivotal Life Sciences is an investment platform that specializes in providing capital to innovative companies developing therapeutic products and technologies to address major unmet medical needs. The name “Pivotal” synthesizes our investment approach with the role we strive to play in the companies we invest in. Our strategy is to invest in companies of all stages, with a primary focused on “high impact” therapeutics – solutions that address growing unmet medical needs and with near-curative or otherwise transformative disease management potential. We look for companies at the cusp of their greatest de-risking value inflection point and strive to play a key role in company building alongside management.

2 jobs
HA

Harmonix

Harmonix invests in technological breakthroughs that will help create a future for a healthy, operational, and peaceful civilization. The fund focuses on exceptional entrepreneurs and innovative healthcare, life sciences, and deep tech companies. Harmonix is a multi-disciplinary team comprising scientists, researchers, operators, entrepreneurs, and industry experts with over 70 years of cumulative experience. Our diverse team provides founders with deep technical, operating, industry, and advisory expertise to accelerate and commercialize the next generation of technological advances. Harmonix accelerates scientific discoveries to advance human health and technology. We invest in companies that have functional solutions to real world problems. The Harmonix Process We deploy an evidence-based due diligence framework in assessing companies. Research: We identify opportunities ripe for innovation and examine areas where current standards of R&D, care, treatment, or workflow processes are inadequate. We find companies with functional solutions to problems that can create real value for stakeholders. Invest: We assess not only the technical dimensions of a venture, including supporting proof-of-concept data but also founder-fund fit. Our team looks for founders with emotional intelligence and demonstrated capacity for leadership and integrity. Accelerate: We support founders in all realms of the entrepreneurial process, including technical, operational, and business development support. We offer access to advisors who provide a level of expertise that is unavailable to many early-stage scientific companies.

LG

Luma Group

Luma Group is passionately leading a transformation in healthcare, driven by a deep-seated commitment to enhance human health. We’re on a mission to turn visionary science into revolutionary healthcare solutions. Our team unites a dynamic mix of investors, scientists, clinicians, and entrepreneurs, all dedicated to advancing human health outcomes. We are not just funding remarkable scientific discoveries; we are investing in the future of humanity. Our focus is on nurturing groundbreaking innovations leveraging advanced computation and artificial intelligence that promise to redefine healthcare, ensuring that every investment we make contributes to a healthier, brighter future for all. Our approach is hands-on and collaborative, partnering with the brightest minds in science, clinical research, engineering, and entrepreneurship. We’re not just investors; we’re co-creators, working side-by-side with innovators and dreamers to transform cutting-edge scientific discoveries into groundbreaking therapeutics, diagnostics, and medical devices. Our goal is clear: to make a significant and lasting impact on human health. Every project we embark on is a step towards redefining what’s possible in healthcare, ensuring that we’re not just part of the conversation, but leading the charge in creating a healthier future for everyone.

PP

Panakes Partners

We back promising teams by providing both financial and business support to build the next generation of game-changing technologies companies in the field of Life Sciences. We invest in ambitious early stage start-ups and SMEs with innovative products globally, mainly across Europe and Israel. We bring strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our founders in accelerating their development. We invest in people, believing that a strong and dedicated team is one of the most important factors in the success of our investments. We aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor. We invest for people, supporting the growth of companies and people that will reshape the medical world, answering real medical needs, saving lives and providing a better quality of life for patients and care-givers. An overall positive impact that will produce intrinsic value for both investors and society.

SL

Shannon Life Sciences

Our mission is to serve as a catalyst for innovation by providing early-stage strategic capital and expert guidance to visionary entrepreneurs and researchers. We're committed to propelling revolutionary technologies and treatments poised to transform healthcare and significantly enhance the lives of patients and their families. About Us At Shannon Life Sciences, we are driven by a passion for innovation. We specialize in identifying and supporting early, groundbreaking ideas that have the potential to revolutionize the treatment of patients. Our team is a mosaic of experts in healthcare, finance, and entrepreneurship. This diverse expertise, coupled with a deep understanding of the healthcare sector and the intricacies of bringing novel therapies to market, positions us to help enable our portfolio companies to be successful. Our role extends beyond funding. We actively engage with academic institutions, visionary entrepreneurs, and industry leaders, forging partnerships that propel cutting-edge therapies and technologies into the healthcare arena.

PP

Polaris Partners

We are an investment firm with more than 25 years of experience backing transformational healthcare and biotech companies. We see the world through an entrepreneur’s eyes. We thrive on collaborating with groundbreaking innovators and repeat entrepreneurs. Our roots are deep in healthcare and science. We have built and nurtured our network over more than two decades – including some of the world’s most prestigious companies, syndicate partners, universities and research institutions. We have built and nurtured our network over more than two decades – including some of the world’s most prestigious companies, syndicate partners, universities and research institutions. Groundbreaking expertiseHealthcare: Our healthcare portfolio companies target innovative care delivery models, such as digital health, consumer-centric businesses, patient and provider solutions, and data science and analytics. Life sciences and biotechnology: Our life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics and genomics.